Behind the Paper
The real stories behind the latest research papers, from conception to publication, the highs and the lows
Why interpreting mountain disasters is not straightforward
Mountain disasters rarely tell a simple story, especially in the immediate aftermath. When the Dharali disaster unfolded, we began asking whether the emerging explanation was fully supported by the evidence. This post reflects on that process and why careful interpretation matters.
Vessel-Controlled Chemodivergence Meets Vinylcyclopropane–Cyclopentene Rearrangement
Our work reveals that the vessel itself dictates product selectivity: switching between glass and plastic enables chemodivergent Rh-catalyzed enantioconvergent rearrangement of vinyl gem-difluorocyclopropanes to cyclopentenones or gem-difluorocyclopentenes.
Urban wetlands: Neglected hotspots of antibiotic resistance genes and key vectors for viral transmission
Our study reveals that urban wetlands, crucial for recreation, flood control, and wildlife habitats, serve as key reservoirs for antibiotic resistance genes, their viral vectors, and bacteria harboring them. This finding underscores a complex interaction between urban ecology and public health.
From Citation to Courtroom: When Research Evidence Shapes Legal Reasoning
A CRISPR funding study cited in a U.S. legal brief reveals how scientific evidence informs judicial reasoning. Beyond academia, research quietly shapes legal arguments about public funding, innovation, and societal impact.
Physical limits to net-zero: how critical minerals reshape the global carbon budget
The transition cannot outrun its material base. While debate fixates on mineral geopolitics, this research identifies a 355 Gt CO2 slippage driven by mining lead times. The real question is not who owns critical minerals, but can they arrive in time? Time to confront the hardware of the transition.
Direct antiviral therapy in patients with HCV: evidence from Saudi Arabia
HCV remains a major global health problem, with a lack of empirical data on HCV in Saudi Arabia. This study investigated the current understanding of the clinical impact of direct-acting antiviral (DAA) on HCV infection in Saudi patients.
